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ABSTRACT
Background To estimate the impact of smoking on quality-adjusted life years (QALY) for US adults aged 65 years and older.
Methods Using the 2003–08 National Health and Nutrition Examination Survey Linked Mortality File, we estimated the mean QALY
throughout the remaining lifetime by participants’ smoking status as well as smoking intensity and time since cessation.
Results Never, former and current smokers had a mean QALY of 16.1, 12.7 and 7.3 years, respectively. Among current smokers, those who
started smoking before age 18 had fewer QALYs than those who started at or after age 18 (6.0 and 8.5 years, respectively) and those smoking
≥20 cigarettes per day had fewer QALYs than those smoking <20 cigarettes per day (6.6 and 8.1 years, respectively). QALYs also declined with
a longer duration of smoking and a shorter time since cessation. The potential gains if a person quit smoking would be 5.4 QALYs, and the
gains would increase with a longer time since quitting as well as quitting at a younger age.
Conclusions This study demonstrated the dose–response effect of smoking status on QALY. The results indicate the health benefits of tobacco
cessation at any age and sizeable losses for former or current smokers.
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Introduction
In the USA, smoking is the leading cause of preventable
death and impacts nearly every organ in the body.1,2
Although some of these adverse health effects may be seen
within minutes to months, other health risks, in the form
of chronic diseases and premature death, may take many
years of smoking to clinically manifest.1 With this in mind,
investigators have quantified the burden of disease attribut-
able to smoking with regard to both increased risk of death
and its associated comorbidities.3–7 These analyses have
been based on a summary index, such as quality-adjusted
life years (QALYs) and disability-adjusted life years
(DALY), that combines both years of life lost and deterior-
ating health status of smokers versus non-smokers.3–7 For
example, Fransen et al. examined the burden of disease for
four modifiable lifestyle factors (smoking, body mass
index, physical activity and diet) in a prospective cohort
study.7 Compared to current smokers, never smokers had
the greatest increase in QALY, a gain that was larger than
the gain from engaging in the other three healthy lifestyle
factors.
Although the risk due to smoking has been portrayed as a
three-level variable (i.e. current, former and never smokers)
or a dichotomous variable (with former smokers excluded
or combined with one of other two categories),4–7 the rela-
tionship between smoking status and health is far more
complex. Factors such as age of initiation, duration of smok-
ing, number of cigarettes smoked per day and number of
pack-years smoked have been noted to play a role in the risk
of developing cancers and other diseases as well as all-cause
mortality.1,8–12 However, these studies did not quantify the
overall burden of disease attributable to these factors in a
single value index, such as QALY or DALY, which reflects
all aspects of health, including both non-fatal illness and pre-
mature death.
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It is difficult to estimate the lifetime impact of smoking
because many smokers begin smoking in their teenage years,
and the health effects of smoking may not be apparent until
decades later. Ideally, a prospective cohort study could
record participants’ smoking status and health conditions on
a regular basis over many decades from the teenage years
until death. To deal with this lack of cohort data, most previ-
ous studies calculating QALY relied on the life table method
that used cross-sectional data by obtaining mortality rates
and health-related quality of life (HRQOL) scores across dif-
ferent ages of the target population.4–6 Therefore, this meth-
od could not be used to examine the effects of factors such
as age of smoking initiation, duration of smoking and smok-
ing cessation at a younger age. An alternative is to examine
these effects in an elderly population using a relatively short
follow-up time because most smokers in this population had
smoked for many decades, enabling exposure information
to be obtained retrospectively. Additionally, because of the
high smoking prevalence 50 years ago, many people in this
population smoked at a younger age, so the impact of fac-
tors such as age of smoking initiation and smoking cessation
could be examined.1
QALY is a health outcome measure that weights life years
lived with preference-based HRQOL scores.13 Preference-
based HRQOL, also called health utility value, is a summary
score that assesses the values of one health state versus
another. The value is anchored at 0 for death and 1 for per-
fect health,14 so 1 year lived in a reduced health state of util-
ity value of 0.5 is equal to 0.5 QALYs, the same as living
one half year in perfect health. Unlike DALY, QALY uses
the health utility value to weight years of life lived and, there-
fore, can be used for calculating the economic costs of a
condition or a risk factor and for analyzing the cost-
effectiveness of alternative treatments, intervention pro-
grams and health policies.4,15,16
However, calculation of QALY throughout the remaining
lifetime is difficult because most participants would still be
alive at the end of follow-up. A recent study proposed a
hybrid method to estimate mean QALY by extrapolating
quality-adjusted survival time beyond the end of follow-up
and demonstrated relatively reliable QALY estimates even
with a small sample size of ~100.17 With the application of
this novel method, the current study examines the burden of
disease attributed to smoking by estimating the dose–
response effect of smoking status on QALY throughout the
remaining lifetime for US adults aged 65 years and older. We
aimed to examine not only smoking status (current, former
and never) but also the age at initiation, number of cigarettes
per day, years of smoking, years since quitting and age last
smoked. Using results from this analysis, we estimated
potential gains in QALY if a person quit smoking by com-
paring current smokers with former smokers (overall, by
years they since quit smoking and by age in which they last
smoked).
Methods
We ascertained respondents’ HRQOL scores and mortality
status from the 2003–04, 2005–06 and 2007–08 cohorts of
the National Health and Nutrition Examination Survey
(NHANES) Linked Mortality File.18,19 The NHANES is an
ongoing survey of random samples from the non-
institutionalized civilian population of the USA.18 With the
use of the design weight and adjustment for non-coverage
and non-response, the distribution of respondents was repre-
sentative of that of the US general population.18 The
NHANES Linked Mortality File was created by the National
Center for Health Statistics by linking the NHANES respon-
dents to the National Death Index.19 The respondents in this
analysis had mortality follow-up through 31 December 2011.
We included only respondents aged 65 years and older, yield-
ing a total sample size of 3652.
The NHANES included a questionnaire that asks respon-
dents to rank their general health from 1 (excellent) to 5
(poor) and to report numbers of their physically unhealthy
days, mentally unhealthy days and days with activity limita-
tion during the past 30 days.20 Because these measures are
not preference-based, they cannot be used to calculate qual-
ity-adjusted life expectancy (QALE) directly.20,21 Thus, this
study employs a previously constructed mapping algorithm
based on respondents’ age and answers to these four ques-
tions to obtain values of a frequently used preference-based
HRQOL measurement, the EuroQol Group’s EQ-5D
index, to calculate QALY.21 This algorithm provides valid
estimates of EQ-5D scores for respondents,21,22 and the
bias of estimated EQ-5D has been estimated to be <1% of
that using the actual EQ-5D questions.22
The NHANES asked participants a number of smoking-
related questions.18 These questions included whether parti-
cipants had smoked at least 100 cigarettes during their life,
whether participants now smoke cigarettes, the age at which
they started to smoke cigarettes regularly, how long it has
been since they quit smoking cigarettes, the age at which
they last smoked cigarettes regularly, and the average num-
ber of cigarettes per day during the past 30 days. These
analyses categorized participants as current smokers, for-
mer smokers and never smokers. The current smokers
were categorized according to number of cigarettes smoked
per day and the age that they started smoking regularly.
Current and former smokers were categorized according to
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number of years smoked. Former smokers were categor-
ized according to how long ago and the age that they had
quit smoking.
Statistical analysis
We applied a hybrid method that calculated QALY from
two parts: QALY during the follow-up period (to 31
December 2011) and QALY beyond the follow-up period
(after 31 December 2011). Details of this method were
described previously.17 To summarize, QALY during the
follow-up period was estimated based on the Kaplan–Meier
method. QALY beyond the follow-up period was estimated
by extrapolating survival time beyond the end of follow-up
using a Weibull model.17
The QALY loss due to current smoking was defined as
the difference in QALY for never smokers and for current
smokers.4,17 Similarly, the QALY loss due to having for-
merly smoked was defined as the difference in QALY for
never smokers and for former smokers. A propensity score
method was used to account for the systematic difference in
participants’ characteristics, such as age and sex, between
persons of different smoking status.23
Results
The average age was 73.7 years (SD = 6.0 years) at the start
of the study (Table 1). Women comprised 55.8% of the
population and non-Hispanic whites comprised 83.8% of
the population. Only 8.0% were non-Hispanic blacks and
5.5% were Hispanics. In this population, the mean EQ-5D
index was 0.827. About 21.2% of participants died during
the follow-up, yielding a mortality rate of 4.06 deaths per
100 person-years. The mean QALY throughout the remain-
der of lifetime was 13.6 years (Table 2), 11.4 years for men
and 16.1 years for women.
With regard to smoking status, only 8.2% of participants
reported currently smoking and 45.2% reported having for-
merly smoked. The mean QALY differed according to
smoking status in the predicted manner (Table 2).
Specifically, never, former and current smokers had a mean
QALY of 16.1, 12.7 and 7.3 years, respectively. This repre-
sented a loss of 3.5 QALYs or 21.5% QALYs for former
smokers and a loss of 8.8 QALYs or 54.8% for current
smokers.
The adverse impact of current and former smoking on
QALY was 3–4 times larger for persons aged 65–74 years
than for persons aged 75 years or older (Fig. 1). Specifically,
QALY losses due to current smoking were 10.4 and 3.3
years for persons aged 65–74 years and for persons aged
75+ years, respectively, and losses due to former smoking
were 5.9 and 1.4 years, respectively. Of note, the much larger
QALY loss for younger participants was mainly because
younger participants had a much larger QALY than older
participants.
The similar patterns between the number of QALYs and
smoking status were observed for both men and women and
for the three racial/ethnic subgroups: 6.9–10.6 years of
QALY lost due to current smoking and 2.6–4.3 years of
QALY lost due to former smoking. Although the QALY
losses due to current and former smoking were greater for
women than men and the losses due to current smoking were
less for non-Hispanic blacks than for non-Hispanic whites
and Hispanics, the differences were not statistically significant.
Among current smokers, those who smoked 20 or more
cigarettes per day had 1.5 QALYs less than those who
smoked <20 cigarettes per day (6.6 versus 8.1 QALYs).
With regard to smoking initiation, those who reported
smoking regularly prior to 18 years of age had 2.5 QALYs
less than those who reported smoking regularly at or after
age 18 (6.0 versus 8.5 QALYs).
Among current and former smokers, QALYs declined and a
greater percentage loss was noted with increasing duration
of smoking. Those who smoked <10 years had a similar
number of QALY as never smokers (16.1 QALYs for both
groups). By contrast, those who had smoked for 50 or more
years had only 6.3 QALYs, a loss of 9.8 QALYs or 60.7%.
Those who reported smoking between 10–29 years and
30–49 years had QALYs that were between the other two
groups (i.e. 14.6 and 11.2 QALYs, respectively).
Table 1 Baseline characteristic, 2003–08 NHANES
Characteristics N % or meana SE
Age: mean (SD) 3652 73.7(6.0)
65–74 1882 56.6% 1.4%
75–84 1481 37.4% 1.2%
≥85 289 6.0% 0.5%
Women 1802 55.8% 0.8%
Race
Non-Hispanic whites 2334 83.8% 1.6%
Non-Hispanic blacks 581 8.0% 1.0%
Hispanics 656 5.5% 0.9%
Other 81 2.7% 0.4%
Died during the follow-up 909 21.2% 1.0%
Mean EQ-5D index 3652 0.827 0.005
Mortalityb 3652 4.06 0.16
aWeighted percentage or mean, accounted for sampling design,
non-coverage and non-response.
bMortality rate, per 100 person-years.
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Among former smokers, those who quit smoking 30 or more
years ago had 14.8 QALYs, a loss of 1.4 QALYs as com-
pared to never smokers; those who quit smoking between
15 and 29 years ago had 12.4 QALYs, a loss of 3.8 QALYs;
and those who quit <15 years ago had 9.1 QALYs, a loss of
7.0 QALYs. Similarly, those who quit smoking before age 40
had 14.3 QALYs, a loss of 1.8 QALYs as compared to
never smokers; those who quit smoking between age 45 and
64 years had 12.3 QALYs, a loss of 3.9 QALYs; and those
who quit after 65 years of age had 9.4 QALYs, a loss of
6.7 QALYs.
Using these results, we estimated ‘potential gains in QALY
if a person quit smoking’ as the difference in QALY between
current smokers and former smokers (Table 3). Overall, the
potential gains would be 5.4 QALYs (73.7%) and the gains
would increase with a longer time since quitting as well as
quitting at a younger age. The potential gains would be 7.5
QALYs (103%) if a person had quit smoking for 30 or more
years and 5.1 QALYs (69.7%) if a person had quit smoking
for between 15 and 29 years. Even if a person quit smoking
for <15 years, he/she could be expected to gain 1.8 QALYs
(24.6%). When examined by age of quitting, the potential gain
would be 7.1 QALYs (96.9%) if a smoker had quit smoking
before age 40; 5.0 QALYs (68.4%) if he/she had quit smok-
ing between age 40 and 64 years; and 2.1 QALYs (28.7%) if
he/she had quit smoking at or after age 65.
Discussion
Main findings of this study
Compared to never smokers, both former and current smo-
kers had sizable losses in QALY and current smokers had a
greater QALY loss than did former smokers. This finding
was noted for both males and females as well as for
Table 2 QALY by smoking status and QALY loss due to smoking, 2003–08 NHANES
Smoking status N Percenta SE QALYb SE Lossc SE % Loss
Total 3652 100% — 13.6 0.9 — — —
Smoking status
Never smokers [reference group] 1704 46.5% 1.2% 16.1 1.4 — — —
Former smokers 1619 45.2% 1.1% 12.7 1.0 3.5 1.2 21.5%
Current smokers 319 8.2% 0.5% 7.3 0.8 8.8 1.5 54.8%
Among current smokers
No. cigarettes per day
<20 168 45.0% 3.8% 8.1 0.8 8.0 0.8 49.7%
≥20 151 55.0% 3.8% 6.6 1.0 9.5 1.0 59.0%
Age start smoking regularly
≥18 years 161 50.4% 4.5% 8.5 0.9 7.6 0.9 47.3%
<18 years 158 49.6% 4.5% 6.0 1.0 10.1 1.0 62.6%
Among former & current smokers
Years of smoking
<10 years 152 9.6% 0.9% 16.1 1.6 0.0 1.3 0.1%
10–29 years 559 32.4% 1.7% 14.6 1.3 1.5 1.3 9.3%
30–49 years 681 39.2% 1.6% 11.2 0.9 5.0 0.9 30.8%
≥50 years 361 18.7% 1.2% 6.3 0.7 9.8 0.7 60.7%
Among former smokers
Years since quit smoking
≥30 years 734 45.1% 1.6% 14.8 1.2 1.4 1.1 8.4%
15–29 years 490 30.8% 1.4% 12.4 1.2 3.8 1.4 23.3%
<15 years 395 24.1% 1.2% 9.1 0.7 7.0 0.7 43.7%
Age last smoked
<40 years 513 33.6% 1.8% 14.3 1.1 1.8 1.0 11.0%
40–64 years 895 55.5% 1.9% 12.3 1.0 3.9 1.3 23.9%
≥65 years 211 10.9% 0.9% 9.4 1.1 6.7 1.1 41.8%
aWeighted percentage, accounted for sampling design, non-coverage and non-response.
bMean QALY throughout remainder of lifetime, adjusted for age and sex for subgroups.
cDecrease in QALY in comparison with never smokers.
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non-Hispanic whites, non-Hispanic blacks and Hispanics.
Among current smokers, a higher daily cigarette consump-
tion and a lower age of initiation resulted in a greater QALY
loss; among former and current smokers, a longer duration
of smoking was associated with less QALY; and among
former smokers, a shorter time since smoking cessation was
associated with less QALY and a younger age of quit smok-
ing was associated with more QALY. There were significant
gains in QALY if a person quits smoking and the gains
would increase with a longer time since quitting as well as
quitting at a younger age.
What is already known on this topic?
Dose response: delayed smoking initiation and
number of cigarettes smoked
These analyses illustrate the ability to reduce some of the
tobacco-related damage by delaying smoking initiation, redu-
cing the number of cigarettes smoked per day and quitting
at an earlier age. Because a younger age of initiation is asso-
ciated with current daily smoking and consuming more
cigarettes per day, efforts should continue to be made to
prevent initiation of smoking among adolescents as well as
into adulthood.24,25 General population surveys indicate that
smokers who consume fewer cigarettes have a lower risk of
heart disease compared to smokers who consume more
cigarettes.26 A systematic review focusing on persons aged
60 years and older revealed a dose–response relationship
between the amount of cigarettes smoked and premature
death.27 By contrast, reducing smoking intensity at mid-life
is associated with a lower mortality risk and higher odds of
surviving to age 80.28
Gains in QALY after quitting smoking
These analyses also illustrate the ability to reduce some of the
tobacco-related damage by encouraging smoking cessation.
Studies of smoking cessation have tended to focus on young-
er smokers, but research suggests that their findings may not
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Fig. 1 QALY loss for former smokers and for current smokers, overall, by
age and gender and for three racial/ethnic subgroups, 2003–08 NHANES
QALY loss, 95% CI Race: W, Non-Hispanic whites; B, Non-Hispanic blacks;
H, Hispanics.
Table 3 Potential gains in QALY after quitting smoking, 2003–08 NHANES
Smoking status N QALYa SE Gainsb SE % Gain
Current smokers [reference group] 319 7.3 0.8 — — —
Former smokers 1619 12.7 1.0 5.4 1.3 73.7%
Years since quitting
≥30 years 734 14.8 1.2 7.5 1.4 102.6%
15–29 years 490 12.4 1.2 5.1 1.4 69.7%
<15 years 395 9.1 0.7 1.8 0.8 24.6%
Age last smoked
<40 years 513 14.3 1.1 7.1 1.3 96.9%
40–64 years 895 12.3 1.0 5.0 1.1 68.4%
≥65 years 211 9.4 1.1 2.1 1.1 28.7%
aMean QALY throughout remainder of lifetime, adjusted for age and sex for subgroups.
bGains in QALY for those who quit smoking as comparison to current smokers.
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programs should target elderly smokers in addition to young-
er and middle-aged smokers, given that even participants who
quit smoking <15 years ago had significantly higher QALY
than current smokers. This finding is consistent with what is
known about the health benefits of smoking cessation at any
age.30,31 Although the elderly might have more opportunities
to interact with the health care system, many were not asked
about their smoking status and elderly smokers might not be
offered counseling to stop smoking.32 A recent analysis of
data from Medicare Advantage participants failed to find sig-
nificant changes in smoking prevalence or cessation from
2005 to 2012, a period during which national smoking cessa-
tion interventions had been implemented.29
What this study adds
Smoking is one of the leading risk factors with regard to the
burden of disease in the USA4,6 and, as such, obtaining a
more detailed portrait of its health impact is critical for pub-
lic health practitioners, policymakers and clinicians. Our
investigation draws upon the work of Jha et al., who calcu-
lated the mortality benefits in quitting at 25–34, 35–44 and
45–54 years of age, by also examining morbidity and focus-
ing on an older population.33 Understanding patterns of
tobacco use and cessation is especially important for the eld-
erly, given that the population aged 65 and older is projected
to nearly double between 2012 and 2050.34 Unlike past stud-
ies, this study was able to examine QALY not only accord-
ing to smoking status (never, former and current) but also
to smoking intensity, time since smoking cessation, age of
smoking initiation and duration of smoking, factors that
have been associated with all-cause mortality in older
adults.35
Limitations of this study
This study examined the long-term health impact of smok-
ing in an elderly population in order to observe any differ-
ence among participants during a much shorter follow-up
time period (i.e. a few years as opposed to many decades).
As a result, the study has a number of noteworthy limita-
tions. First, smoking status was based on self-report and
was not validated by biochemical tests. Second, the number
of cigarettes smoked is based on average cigarettes per day
during the last 30 days only. Third, years of smoking was
estimated based on the age in which the participant began
smoking regularly and his/her current age or age at which
he/she stopped smoking. Since people may smoke intermit-
tently, the actual years of smoking may be less than our esti-
mated value. Fourth, the NHANES did not include the
preference-based HRQOL questions. We used a mapping
algorithm to obtain EQ-5D index scores for respondents
based on their answers to other HRQOL questions.
Estimates of QALY loss would also likely be underestimated
due to regression toward the mean.4 However, a previous
study that examined the bias of QALY estimates showed
that these underestimations were ~2.5% for QALY loss.4
Fifth, due to short follow-up time, this study had to extrapo-
late survival time beyond the end of the follow-up to calcu-
late QALY throughout the remainder of the lifetime. The
extrapolation requires a sufficient number of deaths during
the follow-up in order to obtain a reliable estimation of
QALY. Therefore, this method cannot provide a reliable
QALY estimation for a younger population or groups with
lower mortality.17
In summary, this study estimated the burden of disease
attributable to smoking for US elderly by calculating QALY
throughout the remainder of life according to the partici-
pants’ smoking status. Using QALY provides not only a
comprehensive portrait of smoking’s impact on health but
also a common denominator for the impact of interventions
to be assessed.15,16 This study used a novel method to esti-
mate mean QALY throughout the remaining lifetime and,
therefore, was able to examine the lifetime health impact
according to not only smoking status (never, former and
current) but also to smoking intensity, time since smoking
cessation, age of smoking initiation and duration of smoking.
The results indicate sizeable losses for former or current
smokers and the health benefits of tobacco cessation at any
age. Ultimately, these findings might be of assistance to clini-
cians, public health practitioners and policymakers in their
ongoing efforts to counsel and treat individual patients, imple-
ment public health policies and reduce health disparities.
Ethical statements
This analysis used de-identified data produced by federal
agencies in the public domain. Data were downloaded from
the Centers for Disease Control and Prevention Website
(ftp://ftp.cdc.gov/pub).
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